These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18573861)
1. Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth. Sharma S; Ou J; Strom S; Mattison D; Caritis S; Venkataramanan R Drug Metab Dispos; 2008 Sep; 36(9):1896-902. PubMed ID: 18573861 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes. Sharma S; Ellis EC; Dorko K; Zhang S; Mattison DR; Caritis SN; Venkataramanan R; Strom SC Drug Metab Dispos; 2010 May; 38(5):723-7. PubMed ID: 20097724 [TBL] [Abstract][Full Text] [Related]
3. 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth - A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial. Kuon RJ; Berger R; Rath W Geburtshilfe Frauenheilkd; 2021 Jan; 81(1):61-69. PubMed ID: 33487666 [No Abstract] [Full Text] [Related]
5. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations. Feghali M; Venkataramanan R; Caritis S Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193 [TBL] [Abstract][Full Text] [Related]
6. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth. Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). Zhang S; Mada SR; Sharma S; Torch M; Mattison D; Caritis S; Venkataramanan R J Pharm Biomed Anal; 2008 Dec; 48(4):1174-80. PubMed ID: 18947956 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation. Sharma S; Caritis S; Hankins G; Miodovnik M; Hebert MF; Mattison D; Venkataramanan R Br J Clin Pharmacol; 2016 Oct; 82(4):1084-93. PubMed ID: 27133963 [TBL] [Abstract][Full Text] [Related]
9. Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth. Alizadeh F; Mahmoudinia M; Mirteimoori M; Pourali L; Niroumand S BMC Pregnancy Childbirth; 2022 Mar; 22(1):167. PubMed ID: 35232423 [TBL] [Abstract][Full Text] [Related]
11. Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism. Cuppett CD; Zhao Y; Caritis S; Zhang S; Zhao W; Venkataramanan R Am J Obstet Gynecol; 2013 Jan; 208(1):86.e1-6. PubMed ID: 23063018 [TBL] [Abstract][Full Text] [Related]
12. A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 Production. Megli CJ; Hauspurg A; Venkataramanan R; Caritis SN Am J Perinatol; 2023 Oct; 40(14):1585-1589. PubMed ID: 34784615 [TBL] [Abstract][Full Text] [Related]
13. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate. Stetson B; Hibbard JU; Wilkins I; Leftwich H Obstet Gynecol; 2016 Nov; 128(5):983-988. PubMed ID: 27741201 [TBL] [Abstract][Full Text] [Related]
14. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. EPPPIC Group Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630 [TBL] [Abstract][Full Text] [Related]
15. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. O'Brien JM; Lewis DF Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340 [TBL] [Abstract][Full Text] [Related]